Business Group, with P4ESC, Responds to RFI Regarding Reporting Pharmacy Benefits and Prescription Drug Costs, Section 204 of the CAA

As part of the Partnership for Employer-Sponsored Coverage (P4ESC), the Business Group reiterated concerns regarding potentially onerous employer requirements for pharmacy and prescription reporting in the RFI issued by the Departments. The coalition is working together to raise Departmental awareness and help promote requirements that account for each stakeholders' role.

icon_featured_hand

July 23, 2021

HHS, DOL, and Treasury issued a request for information (RFI) to gather input from the public regarding implementation considerations for the data collection required under section 204 Consolidated Appropriations Act, and the associated impact on group health plans and health insurance issuers. The RFI included many detailed questions, many of which are best answered by the PBMs or other stakeholders.

The Business Group and P4ESC focused our comments on the principles that we believe should shape the regulatory requirements and responsibilities:

  • 1 | identifying ownership and control of the data;
  • 2 | aligning the reporting responsibility with the ownership and control;
  • 3 | limiting the cost burden to employers; and
  • 4 | delaying the initial reporting until the requirements are issued and the parties have developed mechanisms for compliance.

Business Group, with P4ESC, Responds to RFI Regarding Reporting Pharmacy Benefits and Prescription Drug Costs, Section 204 of the CAA

More Topics

Policy & Advocacy icon_right_chevron_dark Compliance icon_right_chevron_dark Pharmacy/Prescription Drugs icon_right_chevron_dark